Why 10x Genomics stock is back in focus after earnings and index changes 10x Genomics (TXG) has been drawing fresh attention ...

Genomics stock has surged 209.7% over the past year, and investors are now weighing that strong run against valuation checks ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

10x Genomics is seeking additional injunctions to protect its intellectual property Since its founding in 2012, 10x Genomics has focused on a broad array of key technologies and intellectual property ...

What Happened? Shares of biotech company 10x Genomics (NASDAQ:TXG) jumped 6.8% in the morning session after Barclays boosted ...

PLEASANTON, Calif., June 20, 2024 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has started shipping its new Xenium Prime 5K ...

PLEASANTON, Calif., May 7, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for ...

10x Genomics is bolstering its commitment to scaling single cell experiments through the acquisition of Scale Biosciences. 10x has agreed to pay $30 million in cash and stock upfront, plus an ...

The latest price target for 10x Genomics (NASDAQ:TXG) was reported by Morgan Stanley on July 9, 2026. The analyst firm set a price target for $37.00 expecting TXG to fall to within 12 months (a ...

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling BRISBANE, Calif.-- ...

NanoString’s GeoMX Digital Spatial Profiler was at the heart of a patent lawsuit filed by 10x Genomics. (NanoString Image) Shares of Seattle-based publicly traded biotech company NanoString ...